Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 2, 2016 | $78.8B |
| FY2017, ended Oct 1, 2017 | $76.4B |
| FY2018, ended Sep 30, 2018 | $70.5B |
| FY2019, ended Sep 29, 2019 | $104B |
| FY2020, ended Sep 27, 2020 | $98.9B |
| FY2021, ended Oct 3, 2021 | $132B |
| FY2022, ended Oct 2, 2022 | $96.7B |
| FY2023, ended Oct 1, 2023 | $104B |
| FY2024, ended Sep 29, 2024 | $110B |
| FY2025, ended Sep 28, 2025 | $94.8B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $119B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 2, 2016 | $21.3B |
| FY2017, ended Oct 1, 2017 | $22.4B |
| FY2018, ended Sep 30, 2018 | $24.7B |
| FY2019, ended Sep 29, 2019 | $26.5B |
| FY2020, ended Sep 27, 2020 | $23.5B |
| FY2021, ended Oct 3, 2021 | $29.1B |
| FY2022, ended Oct 2, 2022 | $32.3B |
| FY2023, ended Oct 1, 2023 | $36.0B |
| FY2024, ended Sep 29, 2024 | $36.2B |
| FY2025, ended Sep 28, 2025 | $37.2B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $38.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 2, 2016 | $2.82B | $3.26B |
| FY2017, ended Oct 1, 2017 | $2.88B | $2.73B |
| FY2018, ended Sep 30, 2018 | $4.52B | $9.96B |
| FY2019, ended Sep 29, 2019 | $3.60B | $3.24B |
| FY2020, ended Sep 27, 2020 | $928M | $114M |
| FY2021, ended Oct 3, 2021 | $4.20B | $4.52B |
| FY2022, ended Oct 2, 2022 | $3.28B | $2.56B |
| FY2023, ended Oct 1, 2023 | $4.12B | $3.68B |
| FY2024, ended Sep 29, 2024 | $3.76B | $3.32B |
| FY2025, ended Sep 28, 2025 | $1.86B | $2.44B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $1.98B | $3.64B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 2, 2016 | $2.13B |
| FY2017, ended Oct 1, 2017 | $2.46B |
| FY2018, ended Sep 30, 2018 | $8.76B |
| FY2019, ended Sep 29, 2019 | $2.69B |
| FY2020, ended Sep 27, 2020 | $4.35B |
| FY2021, ended Oct 3, 2021 | $6.46B |
| FY2022, ended Oct 2, 2022 | $2.82B |
| FY2023, ended Oct 1, 2023 | $3.55B |
| FY2024, ended Sep 29, 2024 | $3.29B |
| FY2025, ended Sep 28, 2025 | $3.22B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $3.45B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 2, 2016 | $3.59B |
| FY2017, ended Oct 1, 2017 | $3.93B |
| FY2018, ended Sep 30, 2018 | $9.44B |
| FY2019, ended Sep 29, 2019 | $11.2B |
| FY2020, ended Sep 27, 2020 | $16.3B |
| FY2021, ended Oct 3, 2021 | $14.6B |
| FY2022, ended Oct 2, 2022 | $15.0B |
| FY2023, ended Oct 1, 2023 | $15.4B |
| FY2024, ended Sep 29, 2024 | $15.6B |
| FY2025, ended Sep 28, 2025 | $16.1B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $13.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 21.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 2, 2016 | 1.46B |
| FY2017, ended Oct 1, 2017 | 1.42B |
| FY2018, ended Sep 30, 2018 | 1.24B |
| FY2019, ended Sep 29, 2019 | 1.18B |
| FY2020, ended Sep 27, 2020 | 1.17B |
| FY2021, ended Oct 3, 2021 | 1.17B |
| FY2022, ended Oct 2, 2022 | 1.15B |
| FY2023, ended Oct 1, 2023 | 1.14B |
| FY2024, ended Sep 29, 2024 | 1.13B |
| FY2025, ended Sep 28, 2025 | 1.14B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | 1.14B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Oct 2, 2016 | $2.00B | $218M | $161M |
| FY2017, ended Oct 1, 2017 | $2.04B | $176M | $151M |
| FY2018, ended Sep 30, 2018 | $7.13B | $250M | $154M |
| FY2019, ended Sep 29, 2019 | $10.2B | $308M | $410M |
| FY2020, ended Sep 27, 2020 | $1.70B | $249M | $299M |
| FY2021, ended Oct 3, 2021 | $0 | $319M | $246M |
| FY2022, ended Oct 2, 2022 | $4.01B | $272M | $102M |
| FY2023, ended Oct 1, 2023 | $984M | $303M | $167M |
| FY2024, ended Sep 29, 2024 | $1.27B | $308M | $108M |
| FY2025, ended Sep 28, 2025 | $0 | $318M | $77.0M |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | — | $364M | $69.3M |
Valuation
At current price- Market Cap
- $117B
- P/E
- 59.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.1×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 27.4×
Growth
Trailing 12 months- Revenue (TTM)
- $38.3B
- Revenue Growth YoY
- 4.5%
- Revenue CAGR 3Y
- 4.9%
- Revenue CAGR 5Y
- 9.6%
- EPS Growth YoY
- −24.7%
- Net Income Growth YoY
- −24.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 7.8%
- Net Margin
- 5.2%
- FCF Margin
- 9.5%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $1.98B
- EPS (diluted)
- $1.74
- EBITDA
- $4.64B
- Operating Income
- $2.98B
Balance Sheet
As of Jun 28, 2026- Cash and cash equivalents
- $3.45B
- Total Debt
- $13.3B
- Net Debt
- $9.83B
- Total Assets
- $28.3B
- Total Liabilities
- $36.0B
- Shareholders' Equity
- −$7.67B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $4.99B
- Capital Expenditure
- $1.34B
- Free Cash Flow
- $3.64B
Dividends and risk
Last 12 months- Dividend Yield
- 2.4%
- Dividend / Share
- $2.48
- Beta (5Y)
- 0.98
Every ratio is calculated from the company’s reported figures.